DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.
美股期货今早高开，其中道指期货上涨约200点。
Shares of DexCom, Inc. (NASDAQ:DXCM) fell sharply during Friday's pre-market trading after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.
DexCom股份（纳斯达克股票代码：DXCM）在周五美股盘前交易中急剧下跌，公司发布了二季度业绩不及预期的收入结果并发布了薄弱的FY24营收预测。
DexCom reported quarterly earnings of 43 cents per share, which beat the analyst consensus estimate of 39 cents. Quarterly sales came in at $1.004 billion which missed the analyst consensus estimate of $1.036 billion.
DexCom报告二季度每股收益为0.43美元，超出分析师平均预估的0.39美元。季度销售额为10.04亿美元，低于分析师预估的10.36亿美元。
DexCom sees third-quarter revenue in a range of $975 million to $1 billion, versus the $1.15 billion estimate, and full-year revenue in a range of $4. billion to $4.05 billion, versus the $4.33 billion estimate.
DexCom将第三季度营收预期区间设定在9750万至10亿美元，低于11.5亿的市场预估值，并将全年营收预期设定在40亿至40.5亿美元之间，而市场预估值为43.3亿美元。
DexCom shares dipped 37% to $68.00 in the pre-market trading session.
DexCom股价在盘前交易中下跌了37% 至68.00美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是在今天美股盘前交易中录得下跌的一些大型股票。
- Zynex, Inc. (NASDAQ:ZYXI) shares declined 21.5% to $8.00 in pre-market trading after the company reported worse-than-expected second-quarter financial results.
- Ur-Energy Inc. (NYSE:URG) shares fell 9.2% to $1.18 in pre-market trading after the company announced a proposed public offering of common shares.
- Tandem Diabetes Care, Inc. (NASDAQ:TNDM) shares declined 9% to $36.99 in pre-market trading. Tandem Diabetes Care will release its second quarter results after the closing bell on Thursday, Aug. 1.
- MacroGenics, Inc. (NASDAQ:MGNX) shares dipped 8.9% to $5.01 in pre-market trading after gaining 5% on Thursday.
- Olin Corporation (NYSE:OLN) shares declined 8.1% to $44.15 in pre-market trading following a second-quarter earnings miss.
- Carter's, Inc. (NYSE:CRI) shares fell 7.4% to $55.40 in pre-market trading following weak quarterly sales.
- Indivior PLC (NASDAQ:INDV) shares fell 4.4% to $12.52 in pre-market trading. Indivior shares jumped 20% on Thursday after the company reported better-than-expected second-quarter financial results and announced an accelerated $100 million share repurchase program.
- Zynex股份（纳斯达克股票代码：ZYXI）在盘前交易中下跌21.5%，至8.00美元，因公司发布了二季度财务业绩低于市场预估值的消息。
- Ur-能源公司（纽交所股票代码：URG）在盘前交易中下跌了9.2%，至1.18美元，因公司宣布拟发行普通股。
- Tandem Diabetes Care公司（纳斯达克股票代码：TNDM）在盘前交易中下跌了9%，至36.99美元。公司将在8月1日星期四收盘后发布第二季度财报。
- MacroGenics股份（纳斯达克股票代码：MGNX）在盘前交易中下跌了8.9%，至5.01美元，之前该公司股价在周四上涨了5%。
- 欧林公司（纽交所股票代码：OLN）在盘前交易中下跌了8.1%，至44.15美元，因公司二季度收益不及预期。
- Carter's公司（纽交所股票代码：CRI）在盘前交易中下跌了7.4%，至55.40美元，因公司季度销售不佳。
- Indivior PLC公司（纳斯达克股票代码：INDV）在盘前交易中下跌了4.4%，至12.52美元。之前该公司发布了业绩优于预期的二季度财务报告，并宣布了一项加速回购计划，公司股价周四飙升了20%。
Now Read This:
现在阅读这个：
- S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone
- 标普500、纳斯达克破位下跌，科技股持续疲弱：贪婪指数处于“恐惧”区间。